Intelligent Bio Solutions Inc
GBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$433.58K
Close$
Share Statistics
| Market cap | $433,577.00 |
|---|---|
| Enterprise Value | $-4,580,203.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2 |
| Beta | 0 |
| Outstanding Shares | 1,594,496 |
Return
| Return on Equity | -129.59% |
|---|---|
| Return on Assets | -78.14% |
| Return on Invested Capital | -119.89% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -2.81 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 0.09 |
| Enterprise Value to Revenue | -1.17 |
| Enterprise Value to EBIT | 0.37 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.4 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GBS Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...